Analyst Information

 

Christopher Raymond

Sr. Research Analyst

Christopher Raymond

 Chris Raymond is a managing director and senior research analyst at Piper Sandler covering the biotechnology sector. Prior to joining Piper, he spent the previous 17 years covering biotechnology at Raymond James, Robert W. Baird and Prudential Vector Healthcare Group. Before that, he spent 10 years with Baxter Healthcare and G. D. Searle in various marketing, business development and strategy roles. Raymond has been recognized twice by StarMine as a top earnings estimator in biotechnology and in 2004 was recognized by The Wall Street Journal "Best on the Street" survey. Raymond received his bachelor’s degree from Michigan State University and his Master of Business Administration degree from the University of Chicago Graduate School of Business. He currently serves on the board of the Financial Markets Institute at Michigan State's Broad College of Business.

Universe Coverage:
Healthcare:   Biotechnology
ABBVAbbVie Inc.
XLRNAcceleron Pharma Inc.
ACRSAclaris Therapeutics, Inc.
AKBAAkebia Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
ALVRAlloVir, Inc.
ALXOALX Oncology Holdings, Inc.
AMGNAmgen Inc.
APTXAptinyx Inc.
ARDXArdelyx, Inc.
BCRXBioCryst Pharmaceuticals, Inc.
BIIBBiogen Inc.
BMRNBioMarin Pharmaceutical Inc.
BPMCBlueprint Medicines Corporation
CBIOCatalyst Biosciences, Inc.
COGTCogent Biosciences, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
GRAYGraybug Vision, Inc.
INOInovio Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
ITOSiTeos Therapeutics, Inc.
KNTEKinnate Biopharma, Inc.
MGTXMeiraGTx Holdings Plc
NUVLNuvalent, Inc.
ONCROncorus, Inc.
OTICOtonomy, Inc.
REGNRegeneron Pharmaceuticals Inc.
RIGLRigel Pharmaceuticals
SLDBSolid Biosciences Inc.
RAREUltragenyx Pharmaceutical, Inc.